More importantly, RGD-TRAIL-ELP induced nearly complete tumor regression without acute liver toxicity and notable change in the body weights after treating the tumor-bearing mice at a dose of 8.25 mg/kg/day. The gene discussed is TNFSF10; the disease is neoplasm.